In conclusion, our results Confirm that the EGFR deletion mutation in exon 19 and T > G substitution mutation in exon 21 polymorphisms are associated with susceptibility to advanced NSCLC in the Egyptians. This evidence concerns the gene EGFR and non-small cell lung carcinoma.